Navigation Links
The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
Date:1/23/2013

CHICAGO, Jan. 23, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the first quarter of FY2013 on Wednesday, January 30, 2013 at 11:00 a.m. Eastern Time (EST). The Company expects to report its operating results earlier the same day.

(Logo: http://photos.prnewswire.com/prnh/20120712/MM39764LOGO)

Shareholders and other interested parties may participate in the conference call by dialing 1-877-374-8416 (international participants dial 1-412-317-6716) and asking to be connected to "The Female Health Company Conference Call" a few minutes before 11:00 a.m. EST on January 30, 2013. 

A replay of the call will be available one hour after the call through 9:00 a.m. EST on Wednesday, February 6, 2013 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID # 10023963.  After February 6, 2013, the replay of the call will be available on the Company's website at www.femalehealth.com.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in the U.S. and approximately 138 other countries globally. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued by the U.S., the European Union, Canada, Australia, South Africa, Japan, The People's Republic of China, Spain, Mexico, Greece, Turkey and the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leona , Sudan, Swaziland, Uganda, Tanzania, Zambia and Zimbabwe. FC2 patent applications are pending in various countries.  The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.  The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings.  Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

For more information about The Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com.


'/>"/>
SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
2. The Female Health Company Reports Second Quarter Operating Results
3. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
4. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
5. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
6. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
7. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
8. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
9. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness ... two patients who tell their personal story and encourage those at risk to get tested ... Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... , May 3, 2016 Intec ... a clinical-stage biopharmaceutical company, today announced the appointment of ... Regulatory Affairs. "Ms. Strauss-Levy has 15 years ... has established an outstanding track record, having supported the ... regulatory approval processes in the United States ...
(Date:5/2/2016)... , May 2, 2016 Kalorama Information noted ... Medical Records) market in a recent white paper.  The ... Increased physician usage, a growing market are among the ... in Kalorama,s report EMR 2016: The Market ... Kalorama,s seventh complete study of the EMR industry, and ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... May kicked off with ... across the United States. Dermatologist Dr. Ellen Turner is encouraging her patients, as well ... and focus on skin safety and health now and in the future. , The ...
(Date:5/4/2016)... ... 04, 2016 , ... Momsense, Inc. has developed ... patented technology, The Smart Breastfeeding Meter, is designed to monitor and measure a ... now available for purchase at Target.com . , Breastfeeding is a ...
(Date:5/4/2016)... ... 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic ... LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her computer, riding ... same day as her in-office consultation and eye exam. Francesca’s eyesight was restored to ...
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare facility ... needed following breast cancer surgery. In March 2016, the 61-year-old model and reality TV ... cancer that occurs in the milk ducts, according to an interview with the ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
Breaking Medicine News(10 mins):